(VIANEWS) – The NASDAQ opens in less than one hour and 10x Genomics‘s pre-market value is already 5.1% up.
The last session, NASDAQ Composite ended with 10x Genomics (TXG) sliding 7.08% to $131.30. NASDAQ Composite dropped 3.34% to $15,100.17, after two consecutive sessions in a row of losses, on what was a very bearish trend trading session.
Today’s last reported volume for 10x Genomics is 591935, 13.49% below its average volume of 684263.
10x Genomics’s last close was $131.30, 37.17% under its 52-week high of $208.99.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s last day, last week, and last month’s current intraday variation average was 7.62%, 4.75%, and 2.18%, respectively.
10x Genomics’s highest amplitude of average volatility was 10.40% (day), 7.24% (last week), and 4.63% (last month), respectively.
More news about 10x Genomics (TXG).